bay-k-8644 has been researched along with inositol 1,4,5-trisphosphate in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (17.65) | 18.7374 |
1990's | 8 (47.06) | 18.2507 |
2000's | 5 (29.41) | 29.6817 |
2010's | 1 (5.88) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Watkins, WD; Whorton, AR; Xuan, YT | 1 |
Biguad, M; Julou-Schaeffer, G; Parratt, JR; Stoclet, JC | 1 |
Ayalon, D; Capponi, AM; Limor, R; Naor, Z; Rossier, MF | 1 |
Coronado, R; Vilven, J | 1 |
Barhanin, J; Frelin, C; Lazdunski, M; Schmid-Alliana, A; Van Renterghem, C; Vigne, P | 1 |
Balla, T; Catt, KJ; Nakanishi, S | 1 |
Bangalore, R; Benson, T; Hinkle, PM; Kass, RS; Li, CC; Nelson, EJ | 1 |
Phillippe, M | 1 |
Lambert, DG; Smart, D; Wandless, A | 1 |
Lambert, DG; Smart, D | 1 |
Helmke, RJ; Martinez, JR; Mörk, AC; Zhang, GH | 1 |
Sarna, SK; Shi, XZ | 1 |
Chida, K; Ichiyama, A; Kanai, M; Nakamura, H; Oki, Y; Suda, T; Uchida, C; Xue, HH; Zhao, DM | 1 |
Arias-Montaño, JA; García, L; Guerrero-Hernández, A; Rueda, A; Soria-Jasso, LE | 1 |
Fischer, JR; Fomin, VP; Gibbs, SG; Hurd, WW; Natarajan, V; Singh, DM | 1 |
Manita, S; Ross, WN | 1 |
Imaizumi, Y; Muraki, K; Ohya, S; Yamamura, H | 1 |
17 other study(ies) available for bay-k-8644 and inositol 1,4,5-trisphosphate
Article | Year |
---|---|
Regulation of endothelin-mediated calcium mobilization in vascular smooth muscle cells by isoproterenol.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Cell Line; Colforsin; Cyclic AMP; Endothelins; Inositol 1,4,5-Trisphosphate; Inositol Phosphates; Isoproterenol; Kinetics; Muscle, Smooth, Vascular; Potassium; Propranolol | 1991 |
Endotoxin-induced impairment of vascular smooth muscle contractions elicited by different mechanisms.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic alpha-Agonists; Animals; Aorta, Thoracic; Caffeine; Calcimycin; Calcium; Clonidine; Endothelium, Vascular; Endotoxins; In Vitro Techniques; Inositol 1,4,5-Trisphosphate; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nitrendipine; Phenylephrine; Potassium Chloride; Rats; Rats, Inbred Strains; Sarcoplasmic Reticulum | 1990 |
Gonadotropin-releasing hormone-induced rise in cytosolic free Ca2+ levels: mobilization of cellular and extracellular Ca2+ pools and relationship to gonadotropin secretion.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Cytosol; Ethers; Exocytosis; Female; Gonadotropin-Releasing Hormone; Inositol 1,4,5-Trisphosphate; Inositol Phosphates; Ionomycin; Kinetics; Luteinizing Hormone; Nifedipine; Pituitary Gland, Anterior; Rats; Rats, Inbred Strains | 1988 |
Opening of dihydropyridine calcium channels in skeletal muscle membranes by inositol trisphosphate.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Barium; Calcium Channels; Inositol 1,4,5-Trisphosphate; Inositol Phosphates; Kinetics; Membrane Potentials; Muscles; Rabbits; Receptors, Nicotinic; Sarcoplasmic Reticulum; Sugar Phosphates | 1988 |
Molecular mechanism of action of the vasoconstrictor peptide endothelin.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Action Potentials; Angiotensin II; Animals; Aorta, Thoracic; Calcium; Calcium Channel Blockers; Calcium Channels; Cell Membrane; Electrophysiology; Endothelins; Endothelium, Vascular; Inositol 1,4,5-Trisphosphate; Inositol Phosphates; Isradipine; Oxadiazoles; Peptides; Phosphatidylinositols; Rats; Rats, Inbred Strains; Vasoconstriction; Vasopressins | 1988 |
Cation sensitivity of inositol 1,4,5-trisphosphate production and metabolism in agonist-stimulated adrenal glomerulosa cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Angiotensin II; Animals; Barium; Calcium; Calcium Channel Blockers; Cations; Cattle; Inositol 1,4,5-Trisphosphate; Inositol Phosphates; Nifedipine; Signal Transduction; Strontium; Type C Phospholipases; Zona Glomerulosa | 1994 |
Inhibition of L-type calcium-channel activity by thapsigargin and 2,5-t-butylhydroquinone, but not by cyclopiazonic acid.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Biological Transport; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium-Transporting ATPases; Hydroquinones; Indoles; Inositol 1,4,5-Trisphosphate; Membrane Potentials; Potassium; Rats; Terpenes; Thapsigargin; Tumor Cells, Cultured | 1994 |
The effects of thimerosal, a sulfhydryl reagent, on phasic myometrial contractions.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Aluminum Compounds; Animals; Calcium; Cytosol; Estrus; Female; Fluorides; In Vitro Techniques; Inositol 1,4,5-Trisphosphate; Ionomycin; Muscle, Smooth; Myometrium; Oxytocin; Potassium Chloride; Proestrus; Rats; Rats, Sprague-Dawley; Thimerosal; Time Factors; Uterine Contraction | 1995 |
Activation of phospholipase C in SH-SY5Y neuroblastoma cells by potassium-induced calcium entry.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Calcium; Calcium Channels; Cells, Cultured; Humans; Inositol 1,4,5-Trisphosphate; Neuroblastoma; Potassium; Time Factors; Type C Phospholipases | 1995 |
Desensitization of the mu-opioid activation of phospholipase C in SH-SY5Y cells: the role of protein kinases C and A and Ca(2+)-activated K+ currents.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Analgesics, Opioid; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Cyclic AMP-Dependent Protein Kinases; Enzyme Activation; Enzyme Inhibitors; Fentanyl; Humans; Indoles; Inositol 1,4,5-Trisphosphate; Isoquinolines; Narcotics; Neuroblastoma; Nifedipine; Potassium Channels; Protein Kinase C; Receptors, Opioid, mu; Sensitivity and Specificity; Sulfonamides; Tumor Cells, Cultured; Type C Phospholipases | 1995 |
Regulation of cytosolic free Ca2+ in cultured rat alveolar macrophages (NR8383).
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adenosine Triphosphate; Animals; Calcium; Calcium-Transporting ATPases; Cells, Cultured; Cytosol; Enzyme Inhibitors; Imidazoles; Inositol 1,4,5-Trisphosphate; Macrophages, Alveolar; Membrane Potentials; Rats; Receptors, Purinergic P2; Thapsigargin; Zymosan | 1997 |
Impairment of Ca(2+) mobilization in circular muscle cells of the inflamed colon.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Acetylcholine; Animals; Calcium; Calcium Channel Agonists; Calcium Radioisotopes; Cell Membrane Permeability; Cell Size; Colitis; Cytosol; Dogs; Inositol 1,4,5-Trisphosphate; Kinetics; Muscle Contraction; Muscle, Smooth; Potassium Chloride; Ryanodine; Tritium | 2000 |
Effect of erythromycin on ATP-induced intracellular calcium response in A549 cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adenosine Triphosphate; Anti-Bacterial Agents; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Erythromycin; Estrenes; Humans; Inositol 1,4,5-Trisphosphate; Intracellular Membranes; Lung; Nickel; Potassium Chloride; Protein Isoforms; Pyrrolidinones; Receptors, Purinergic P2; Receptors, Purinergic P2X2; Tumor Cells, Cultured; Uridine Triphosphate; Verapamil | 2000 |
The initial inositol 1,4,5-trisphosphate response induced by histamine is strongly amplified by Ca(2+) release from internal stores in smooth muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Androstadienes; Animals; Calcium; Carbachol; Cimetidine; Extracellular Space; Guinea Pigs; Histamine; Histamine Agonists; Inositol 1,4,5-Trisphosphate; Kinetics; Lithium; Muscle, Smooth; Pyrilamine; Ryanodine; Thapsigargin; Type C Phospholipases; Urinary Bladder; Wortmannin | 2002 |
Magnesium sulfate inhibits the oxytocin-induced production of inositol 1,4,5-trisphosphate in cultured human myometrial cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Cell Culture Techniques; Cells, Cultured; Drug Interactions; Egtazic Acid; Female; Humans; Inositol 1,4,5-Trisphosphate; Magnesium Sulfate; Myometrium; Nifedipine; Oxytocin; Sodium Fluoride | 2002 |
Synaptic activation and membrane potential changes modulate the frequency of spontaneous elementary Ca2+ release events in the dendrites of pyramidal neurons.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Animals, Newborn; Biophysical Phenomena; Caffeine; Calcium; Calcium Channel Agonists; Computer Simulation; Dendrites; Electric Stimulation; Excitatory Amino Acid Agents; GABA Antagonists; Hippocampus; In Vitro Techniques; Inositol 1,4,5-Trisphosphate; Membrane Potentials; Models, Neurological; Organic Chemicals; Patch-Clamp Techniques; Phosphodiesterase Inhibitors; Picrotoxin; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Sodium Channel Blockers; Synapses; Tetrodotoxin | 2009 |
Involvement of inositol 1,4,5-trisphosphate formation in the voltage-dependent regulation of the Ca(2+) concentration in porcine coronary arterial smooth muscle cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channels; Coronary Vessels; Heparin; Inositol 1,4,5-Trisphosphate; Inositol 1,4,5-Trisphosphate Receptors; Membrane Potentials; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Potassium Channels; Swine | 2012 |